Product image of Lidex (Fluocinonide) supplied by GNH India

Lidex

Active Ingredient:
Fluocinonide
Origin:
EU

Lidex (Fluocinonide)

Fluocinonide, the active ingredient in Lidex, is a potent glucocorticoid corticosteroid presented as a topical formulation for cutaneous use. It is indicated for inflammatory skin conditions, reducing redness, swelling, and itching in patients with eczema, psoriasis, dermatitis, and related disorders. Applied directly to the affected area, it modulates local immune responses with minimal systemic absorption when used as directed.

GNH India supplies Lidex as a licensed, GDP‑compliant supplier to hospitals, pharmacies and clinics worldwide. The company adheres to international quality standards and provides regulatory documentation for export.

Manufacturer / TM Owner

Galenica Sa

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Fluocinonide is a topical corticosteroid that acts on inflammatory skin disorders.

  • Eczema: Reduces inflammation, itching and redness associated with atopic dermatitis.
  • Psoriasis: Decreases plaque thickness and scaling in plaque‑type psoriasis.
  • Dermatitis: Controls acute flare‑ups of contact or seborrheic dermatitis.
  • Other inflammatory skin disorders: Provides symptomatic relief in conditions such as lichen planus or discoid lupus erythematosus.
  • Pruritus associated with chronic skin disease: Alleviates persistent itching.

How It Works

  • Fluocinonide binds to intracellular glucocorticoid receptors, forming a complex that translocates to the nucleus and alters gene transcription. This down‑regulates pro‑inflammatory cytokines, reduces leukocyte migration, and suppresses immune cell activation, leading to decreased inflammation, edema, and epidermal hyperproliferation in the skin.

Side Effects

Topical fluocinonide may cause local and systemic adverse reactions.

Common Side Effects

  • Burning or stinging sensation at the application site
  • Skin dryness or peeling
  • Pruritus or mild irritation
  • Folliculitis or acneiform eruptions
  • Localized erythema
  • Skin atrophy with prolonged use

Serious or Rare Side Effects

  • Secondary bacterial, fungal or viral skin infection
  • Hypothalamic‑pituitary‑adrenal (HPA) axis suppression
  • Severe allergic reaction (e.g., angioedema, urticaria)
  • Extensive skin thinning or striae formation
  • Delayed wound healing
  • Systemic glucocorticoid effects with extensive application

Precautions & Warnings

Use Lidex only under medical supervision and follow prescribed instructions.

  • Avoid application to infected, ulcerated or broken skin: risk of systemic absorption and infection.
  • Limit use on large body surface areas: reduces potential systemic effects.
  • Use the lowest effective potency and shortest duration needed for control.
  • Monitor for signs of adrenal suppression, especially with prolonged therapy.
  • Discontinue if severe irritation or allergic reaction occurs.
  • Store at room temperature: keep in the original container, protect from moisture and light.

Avoid Interactions

Fluocinonide may interact with other agents that affect immune function or skin integrity.

Major Interactions (Avoid)

  • Systemic corticosteroids: additive risk of systemic glucocorticoid effects.
  • Cyclosporine or other potent immunosuppressants: increased immunosuppression and infection risk.

Moderate Interactions (Monitor Closely):\n- Antifungal or antiviral topical agents: may alter absorption and increase irritation.

  • Non‑steroidal anti‑inflammatory drugs (NSAIDs) applied to the same area: potential for enhanced local irritation.
  • Live vaccines: topical steroids may diminish local immune response to the vaccine.

Frequently Asked Questions

Lidex contains fluocinonide, a potent topical corticosteroid indicated for inflammatory skin disorders such as eczema, psoriasis, various forms of dermatitis and other conditions where reduction of redness, swelling and itching is required.

Fluocinonide binds to glucocorticoid receptors inside skin cells, altering gene transcription. This suppresses the production of inflammatory cytokines, reduces leukocyte migration, and limits epidermal cell proliferation, resulting in decreased inflammation and symptom relief.

The dosage and frequency of Lidex are determined by the prescribing healthcare professional based on the specific condition, severity, patient age and treatment response. Patients should follow the exact instructions provided on the prescription label.

Safety data for fluocinonide in pregnancy and lactation are limited. The product should only be used if the potential benefit justifies any potential risk to the fetus or infant, and this decision must be made by a qualified prescriber.

To request Lidex, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Lidex (fluocinonide) is a high‑potency corticosteroid, generally more potent than mid‑strength agents such as betamethasone dipropionate but less potent than ultra‑high agents like clobetasol propionate. Choice of therapy depends on disease severity, body area treated and duration of use.

Lidex should be stored at room temperature, below 25 °C, in its original packaging. Keep the tube tightly closed, protect it from moisture and direct sunlight, and keep it out of reach of children.

Apply a thin layer of the cream or ointment to the affected skin area once or twice daily, as directed by the prescriber. Wash hands before and after application, and avoid contact with eyes, mouth or open wounds unless specifically instructed.

Serious risks include secondary skin infections, hypothalamic‑pituitary‑adrenal axis suppression, severe allergic reactions, extensive skin thinning or striae, and systemic glucocorticoid effects when large areas are treated for prolonged periods.

Lidex is contraindicated in patients with known hypersensitivity to fluocinonide or any formulation component, in untreated viral, fungal or bacterial skin infections, and on skin that is severely damaged, ulcerated or at risk of systemic absorption without medical supervision.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Fluocinonide

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT